As European markets experience a positive upswing, with the pan-European STOXX Europe 600 Index rising by 3.44% amid easing tariff concerns, investors are keenly observing opportunities for potential value investments. In this context, identifying stocks that are trading below their intrinsic value can be particularly appealing, offering a chance to capitalize on market optimism while potentially mitigating risks associated with broader economic uncertainties.
Name | Current Price | Fair Value (Est) | Discount (Est) |
Truecaller (OM:TRUE B) | SEK75.15 | SEK148.30 | 49.3% |
Lectra (ENXTPA:LSS) | €24.10 | €47.78 | 49.6% |
BICO Group (OM:BICO) | SEK34.36 | SEK67.23 | 48.9% |
FACC (WBAG:FACC) | €7.08 | €14.09 | 49.8% |
High Quality Food (BIT:HQF) | €0.576 | €1.13 | 48.8% |
ATON Green Storage (BIT:ATON) | €1.92 | €3.83 | 49.9% |
W5 Solutions (OM:W5) | SEK76.40 | SEK151.39 | 49.5% |
Bactiguard Holding (OM:BACTI B) | SEK31.80 | SEK62.19 | 48.9% |
Obiz (ENXTPA:ALBIZ) | €4.39 | €8.65 | 49.3% |
Longino & Cardenal (BIT:LON) | €1.36 | €2.65 | 48.7% |
Click here to see the full list of 175 stocks from our Undervalued European Stocks Based On Cash Flows screener.
Let's review some notable picks from our screened stocks.
Overview: Stora Enso Oyj offers renewable solutions for packaging, biomaterials, wooden constructions, and paper industries in Finland and globally, with a market cap of approximately €6.70 billion.
Operations: The company's revenue segments include Forest (€3.00 billion), Biomaterials (€1.61 billion), Wood Products (€1.59 billion), Packaging Materials (€4.56 billion), and Packaging Solutions (€1.00 billion).
Estimated Discount To Fair Value: 32.9%
Stora Enso Oyj is trading at €8.24, significantly below its estimated fair value of €12.27, suggesting it may be undervalued based on cash flows. Recent earnings showed improved net income of €113 million for Q1 2025, up from €79 million the previous year. The company is reorganizing to enhance focus on renewable packaging, which constitutes 60% of its revenue and aligns with sustainability trends. Despite a low forecasted return on equity and challenges in covering dividends with earnings or free cash flow, expected profitability growth remains strong over the next three years.
Overview: Gjensidige Forsikring ASA, along with its subsidiaries, offers general insurance and pension products across Norway, Sweden, Denmark, Finland, Latvia, Lithuania, and Estonia with a market cap of NOK124.29 billion.
Operations: Gjensidige Forsikring ASA generates revenue from several segments: NOK15.60 billion from General Insurance Private, NOK21.43 billion from General Insurance Commercial, NOK2.00 billion from General Insurance Sweden, and NOK893.50 million from Pension products.
Estimated Discount To Fair Value: 32.1%
Gjensidige Forsikring ASA, trading at NOK 248.6, is considerably below its estimated fair value of NOK 366. The company's Q1 2025 earnings reveal a net income increase to NOK 1.34 billion from NOK 821.5 million the previous year, reflecting robust cash flow generation. With earnings forecasted to grow faster than the Norwegian market and a high return on equity expected in three years, Gjensidige presents potential as an undervalued stock based on cash flows.
Overview: Truecaller AB (publ) develops and publishes mobile caller ID applications for individuals and businesses across India, the Middle East, Africa, and internationally, with a market cap of approximately SEK25.78 billion.
Operations: The company generates revenue from its Communications Software segment, amounting to SEK1.88 billion.
Estimated Discount To Fair Value: 49.3%
Truecaller, trading at SEK 75.15, is significantly undervalued with a fair value estimate of SEK 148.3. The company's earnings are projected to grow significantly above the Swedish market rate, supported by strong partnerships like those with Fawry and Telecom Egypt, enhancing customer communication and security. Despite a dividend yield of 2.26% not fully covered by free cash flows, Truecaller's robust growth prospects and strategic client collaborations underscore its potential as an undervalued stock based on cash flows.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include HLSE:STERV OB:GJF and OM:TRUE B.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.